WO1997037723A1 - Procede et dispostif ameliores de retraction de collagene induite au laser - Google Patents
Procede et dispostif ameliores de retraction de collagene induite au laser Download PDFInfo
- Publication number
- WO1997037723A1 WO1997037723A1 PCT/US1997/003449 US9703449W WO9737723A1 WO 1997037723 A1 WO1997037723 A1 WO 1997037723A1 US 9703449 W US9703449 W US 9703449W WO 9737723 A1 WO9737723 A1 WO 9737723A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- die
- tissue
- laser energy
- collagen
- laser
- Prior art date
Links
- 108010035532 Collagen Proteins 0.000 title claims abstract description 110
- 102000008186 Collagen Human genes 0.000 title claims abstract description 110
- 229920001436 collagen Polymers 0.000 title claims abstract description 110
- 238000000034 method Methods 0.000 title claims abstract description 72
- 238000001816 cooling Methods 0.000 claims abstract description 20
- 230000008602 contraction Effects 0.000 claims abstract description 9
- 210000003041 ligament Anatomy 0.000 claims description 8
- 206010016654 Fibrosis Diseases 0.000 claims description 7
- 230000036760 body temperature Effects 0.000 claims description 7
- 230000004761 fibrosis Effects 0.000 claims description 7
- 230000037303 wrinkles Effects 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 5
- 238000002679 ablation Methods 0.000 claims description 4
- 230000007704 transition Effects 0.000 claims description 4
- 239000012780 transparent material Substances 0.000 claims description 2
- 230000001815 facial effect Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 80
- 210000002808 connective tissue Anatomy 0.000 abstract description 19
- 230000006378 damage Effects 0.000 abstract description 14
- 230000008569 process Effects 0.000 abstract description 8
- 230000036407 pain Effects 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 210000002346 musculoskeletal system Anatomy 0.000 abstract description 2
- 230000003595 spectral effect Effects 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 45
- 210000002435 tendon Anatomy 0.000 description 17
- 239000000835 fiber Substances 0.000 description 16
- 239000010410 layer Substances 0.000 description 16
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000005855 radiation Effects 0.000 description 8
- 230000008033 biological extinction Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 229920002683 Glycosaminoglycan Polymers 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000001427 coherent effect Effects 0.000 description 3
- 230000001066 destructive effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000002344 surface layer Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 208000006787 Port-Wine Stain Diseases 0.000 description 2
- 108010077465 Tropocollagen Proteins 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000002428 photodynamic therapy Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229910052594 sapphire Inorganic materials 0.000 description 2
- 239000010980 sapphire Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000003685 thermal hair damage Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000003454 tympanic membrane Anatomy 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020675 Hypermetropia Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010067193 Naevus flammeus Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000035571 calor Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000002334 cicatricial ectropion Diseases 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 210000000027 corpus adiposum orbitae Anatomy 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035620 dolor Effects 0.000 description 1
- 238000004980 dosimetry Methods 0.000 description 1
- 201000003079 ectropion Diseases 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 208000002026 familial multiple nevi flammei Diseases 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 201000006318 hyperopia Diseases 0.000 description 1
- 230000004305 hyperopia Effects 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012978 minimally invasive surgical procedure Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 1
- 239000000906 photoactive agent Substances 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 208000014733 refractive error Diseases 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000036185 rubor Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 238000001988 small-angle X-ray diffraction Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
- A61B2018/00029—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B2018/2015—Miscellaneous features
- A61B2018/2025—Miscellaneous features with a pilot laser
Definitions
- This mvention relates to an improved method and device for laser induced sli ⁇ nktng of collagen in humans and other animals
- a preferred embodiment of this novel method is directed to the shrinking of collagen in the skin for removing wrinkles and other aesthetic and medical applications, without causing superficial stun damage
- Another preferred embodiment of this novel method is directed to the therapeutic contraction of the collagen connective tissue withm the musculoskeletal system
- Collagen is the single most abundant animal protein in mammals, accounting for up to 30% of all proteins
- the collagen molecule after being secreted by the fibroblast cell, assembles into charactenstic fibers responsible for the functional integnty of tissues making up most organs in the body
- the skin is the largest organ of the body occupying the greatest surface area withm the human body As age advances and as a result of other noxious stimuli, such as the increased concentration of the ultraviolet part of the electromagnetic spectrum as radiated from the sun, structural integnty and elasticity of skin diminishes
- Shrinkage temperature may be defined, therefore, as the specific point at which disruptive tendencies exceed the cohesive forces in this tissue. This temperature, thus, makes this an actual measurement of the stability of the collagen bearing tissue expressed in thermal units.
- the cause of wrinkles around the eyelids, mouth and lips is multifactorial: photodamage, smoking and muscular activity such as squinting and smiling all contribute.
- the end result is a general loss of elasticity, which is a textural skin condition as opposed to a skin redundancy or excess of skin tissue.
- the surgical injection of reconstituted collagen is commonly used in order to flatten the penoral lines.
- tendons serve as the mechanical link connecting muscle with skeleton and, thus, must possess high tensile modulus, high toughness and good resistance to tensile creep, fatigue and shock Tendon, however, must be flexible enough to bend at joints and absorb slack when muscle tone is relaxed This is true, also, of ligaments which serve to connect individual bones and are important in maintaining the integnty of joint structures It is the hierarchical organization of ligamcntous and tendon collagen, as well as the annulus fibrosis component of the intervertebral disc which permit their unique qualities
- the present invention is an improved method and device for shrinking collagen
- collagen connective tissue in skin can be contracted or shrunk instantaneously, thus tightening the overlying tissue without the superficial damage or destruction associated with other techniques of superficial skin resurfacing
- the method and device is highly beneficial in therapeutic contraction of die collagen connective tissue within the musculo-skelctal system
- These techniques match the thickness of the target tissue with the extinction depth or the spectral abso ⁇ tion coefficient of the specific laser wave length to gently heat the collagen molecule to the thermal shrinkage temperature, thus resulting m shrinkage of the underlying tissue while tightening the overlying skin
- Superficial heat exchange either by means of passive, or more effectively, by means of a dynamic cooling process enhance this modality by eliminating pain or discomfort and reducing any nsk of superficial destruction of the skin tissue
- the present invention is a method for sh ⁇ nking connective collagen tissue compnsing the step of irradiating the tissue with laser energy having a wavelength in the range of about 1 to about 12 microns.
- the temperature of the collagen to be shrunk is raised to between about 58 and about 62 degrees Celsius In a preferred embodiment, the temperature of the collagen to be shrunk is raised to about 60 degrees Celsius
- the energy has a wavelength in the range of about 1.2 to about 1 8 microns In a preferred embodiment, the energy has a wavelength of about 1 3-1 4 microns
- the energy is delivered in a contmuous wave In a preferred embodiment, the energy is delivered in a pulsed mode.
- the pulse rate of delivery of the laser energy is such that the pulses of energy are delivered within the thermal relaxation time period for the given volume of tissue being thermally treated.
- the total energy delivered is in the range of about 4 to about 50 joules per square centimeter.
- the present invention is a method of removing wrinkles or other tissue by shrinking the connective collagen of the target tissue comprising the step of delivering laser radiation having a thermal extinction coefficient such that the laser energy is absorbed by the target tissue below the surface of the skin.
- the laser energy is absorbed a t a depth of between about 0.01 and about 25 millimeters which corresponds to the extinction coefficient of the energy having a wavelength of between 1 and 12 microns.
- the method comprises the step of providing a heat sink on the surface of the skin to prevent significant thermal increase at the surface of the skin.
- the heat sink is a suitable laser transparent material.
- the heat sink is a suitable dynamic cooling system.
- the energy has a wavelength in the range of about 1 to about 12 microns. In a preferred embodiment, the energy has a wavelength in the range of about 1.2 to about 1.8 microns. In a preferred embodiment, the energy has a wavelength of about 1.3- 1.4 microns. It has been observed that laser energy having a wavelength of between about 1.3 and 1.4 microns has an extinction coefficient of about 1.8 cm "1 . This corresponds to a depth of penetration of about 5.5 millimeters, the inverse of the extinction coefficient.
- the present invention is a novel method for shrinking collage in joints, ligaments and musculoskclctal tissue comprising the step of irradiating the tissue with laser energy having a wavelength in the range of about 1 to about 12 microns.
- the energy has a wavelength in the range of about 1.2-1.8 microns.
- the energy has a wavelength of about 1.3-1.4 microns.
- the present invention is a novel system for shrinking collagen tissue comprising a source of laser energy, the laser energy having a predetermined wavelength such that the laser energy is absorbed at a point in the tissue significantly below tiie surface of the skin, thereby preventing ablation or charring of the surface tissue, and a laser delivery device, the laser delivery device capable of dehve ⁇ ng a precise amount of laser energy to the tissue to be shrunk at a predeteirriined rate
- the laser energy has a wavelength in the range of about 1 and about 12 microns
- d e laser energy has a wavelength in the range of about 1 2 and about 1 8 microns
- the energy has a wavelength of about 1 3-1 4 microns
- the invention further compnses a passive heat sink.
- the invention further comprises a dynamic heat sink
- the invention further comprises a microprocessor and a controller for controlling d e delivery of laser energy by die laser delivery device to the tissue
- die mvention further comp ⁇ ses a thermal scnsmg system
- FIG 1 is a cross-section view of typical skin tissue
- FIG 2 is a diagram showing collagen phase transition from d e molecule's tnple helical extra-cellular matrix native state at normal body temperature to states at the thermal shrinkage temperature wherein the collagen fibnls are both under tension and relaxed
- FIG 3 is a schematic representation of die hierarchical structure of collagen in d e tendon
- FIG 4 is a schematic representation of e macromolecular structure of the lntervertebral
- FIG 5 is a graph demonstrating the temperature gradient through a portion of die skin as a function of both die wavelength of incident laser energy and die depth of laser radiation penetration
- FIG 6 is a schematic view of a hand held temperature controlled collagen sh ⁇ nkage device used in die method of the present invention.
- FIG. 7 is a graph demonstrating d e temperature gradient through a portion of die skin widi precooling as a function of both the wavelength of incident laser energy and die depth of laser radiation penetration.
- FIG. 8 is a schematic view of a microscope mounted scanner for a temperature controlled collagen shrinkage device used in die present invention.
- FIG. 1 is a cross-section view of typical skin tissue.
- the uppermost layer 98 of typical skin tissue is composed of dead cells which form a tough, horny protective coating.
- Intertwining S-like finger shaped portions 104 are at d e interface between die epidermal papillary layer 106 and die dermal papillary layer 108, and extend downward.
- Beneadi die dermis is die subcutaneous tissue 110, which often contains a significant amount of fat.
- d ough viable collagen connective tissue also exists to a certain degree in die lower subcutaneous layer as well.
- Other structures found in typical skin include hair and an associated follicle 112, sweat or sebaceous glands and associated pores 114, blood vessels 116 and nerves 118.
- a pigment layer 120 might be present.
- mat die drawing is representative of typical skin and mat die collagen matrix will take different forms in different parts of the body. For example, in die eyelids and cheeks die dermis and subcutaneous layers are significantly thinner with less fat dian in otiier areas.
- the target depdi will be a function of die amount of scattering in the particular skin type and die associated abso ⁇ tion coefficient of d e tissue.
- d e actual target depdi will correspond to one half d e thickness of die subject tissue
- die target depdi of tissue '/. inch duck might be about % inch below die surface of die skin
- FIG 2 is a diagram showing collagen phase transition from die molecule's tnple helical extra-cellular matnx native state 30 at normal body temperature to states at the tiiermal shrinkage temperature wherem die collagen fibrils are bodi under tension 32 and relaxed 34
- the molecular structure of collagen in its native state is mat of a triple coiled or helical crystalline protem structurally embedded widnn a umque ground substance Among these unique properties are its strength and its elasticity which an analogy to nylon might be drawn
- Anodicr significant similanty with nylon is collagen's ability to undergo diermal modification resulting in the contraction or shrmking of d e molecule without die substantial loss of its strength and elasticity
- Widnn a small diermal window of 4 to 5 degrees Celsius at about 23 degrees Celsius above body temperature, die collagen molecule will undergo a contraction to 1/3 of its o ⁇ ginal lengdi, without biochemical change If this "diermal sh ⁇ nkage temperature" (T s ) is not
- the approp ⁇ ate wave lengdi is approximately between about 1 and about 12 microns, preferably between about 1 2 and about 1 8 microns, and more preferably about 1 3-1 4 microns
- This ideal wavelength depends upon die abso ⁇ tion of die radiation by water order to elevate die temperature of die target tissue to T s for collagen sh ⁇ nkage - a temperature below that which results in protein denaturation
- the Nd YAG, Nd YAP and Nd YALO- ype lasers are such sources of coherent energy This wavelength of 1 3-1 4 microns is absorbed relatively well by water, and as a result is attractive for tissue interaction It is also easily transmitted through a fiber optic delivery system as opposed to die ngid articulated arm required for me C0 2 laser Very precise mediods of controlling laser systems and optically filtering produced light currently exist By selecting die approp ⁇ ate combination of resonance optics and/or anti-reflection coatings, wavelengths in die range of 1 3-1 4 microns and even 1 32-1 34 microns can be produced
- FIG 3 is a schematic representation of the hierarchical structure of collagen in die tendon
- the hierarchical orgamzation of connective tissues is illustrated in die tendon 130
- virtually all connective tissues, whether soft or hard have hierarchical structural designs arranged at discrete levels of structure
- This hierarchical organization of diesc and other collagen bearing tissues have been widely studied and reviewed
- Beginning at die molecular level with tropocollagcn progressively larger and more complex structures are built up on die nano- and microscopic scales
- die tropocollagcn helix 132 These molecules aggregate to form microfibnls 134 which, m turn, are packed into a lattice structure forming a subfib ⁇ l 136
- the subfib ⁇ ls are men joined to form fibrils 138 in which die characteristic structural 64-nannometer banding pattern is evident
- the fascicle 140 At the fascicular level the
- die elements absorb energy and protect die tendon as a whole from catastrophic failure. It is die current view diat proteoglycans in association witii copious amounts of water come into play as a matrix binding die fibrils togetiier. Proceeding toward macroscopic dimensions, die fascicles comprising crimped collagen fibrils are embedded in die proteoglycan-water gel witii several fascicles in turn making up the functioning tendon or ligament.
- FIG. 4 is a schematic representation of the macromolecular structure of the intervertebral disc 150.
- intervertebral discs are interspersed between die vertebral bones in die spinal column.
- One of the functions of the discs is to absorb compressive forces or loads placed on die spine and skeletal structure while moving or performing functions.
- diat the annulus fibrosis 152 the outer component of die intervertebral disc diat is made up of discrete layers or lamellae 154 of fibrous collagen arrayed around die nucleus like the layers of an onion skin.
- the hierarchical structure with gradient characteristics at die various levels of organization is not unlike that of tendon or ligamentous tissues.
- the collagen fibrils organized into lamellar sheets in die annulus fibrosus surround a gelatinous and highly hydrated nucleus pulposis 156.
- the thickness of lamellae vary with location and are thicker at the anterior and lateral aspects of die disc than at the posterior.
- fibrils are parallel and inclined with respect to die axis of die spinal column by an intcrlamcllar angle A which alternates in successive lamellae. This angle decreases from die edge of the disc inward.
- die fibrils have a planar zig-zag waveform.
- the crimp angle B is largest in fibrils close into tiie nucleus and decreases toward die periphery.
- die collagen fibrils in the annulus gives the disc strength and stability in tension, bending, and torsional motions. Based upon optical microscope observations of die mo ⁇ hology of die collagen fibrils, die levels of structural hierarch below die fibrils are assumed to be identical to diat of the tendon and intestine. Axial compression, in addition to torsion and bending, is a mode of deformation normally experienced by the disc.
- die restoring force of die stretched fibers of the annulus is considered to balance die effects of nuclear pressure
- the fibers of die lamellae are constrained at the cartilage end-plates of the vertebral bodies, so they must extend in length to accommodate die bulging Even though the disc undergoes macroscopic compression, die fibers of the lamellae are loaded in tension and their mode of deformation can be compared witii other connective tissues such as tendon and intestine
- This type of tissue belongs to die family of umaxial composites
- the significant aspect of a composite is its unique set of mechamcal properties This is achieved through die synergistic mechamcal inte ⁇ lay between structural elements
- the slippage mechamsm by which a collagen fibril elongates involves slippage of the tropocollagen umts within die microfib ⁇ l This requires over coming the lateral bonding forces but does not result in tiiese forces being completely and permanently destroyed Load bearing ability is maintained, or even improved, when uitrafibnllar stra hardemng occurs
- the mucopolysaccha ⁇ de matnx plays a secondary role
- the most obvious mechamcal function of die matnx is to bind the collagen fibrils into a functional sliding cord
- This matrix which is more currently charactenzed as glycosaminoglycan or GAG, serves to cement the fibers together into fiber bundles and provides the lateral bonding force required for load bearing
- die benefit of die use of mid-infrared laser energy withm the spectra abso ⁇ tion or extinction coefficient range of 0 4 cm ' - 1000 cm ' corresponding to the wavelength range withm the electromagnetic spectrum of 1 0 microns to 12 0 microns for the shrinkage of collagen connective tissues are as follows shnnkage of the medial or lateral collateral , or the ante ⁇ or cruciate ligament of the unstable knee joint and the treatment of the chrome unidirectional and multidirectional glcnohumeral instability or tightening of die shoulder capsule in recurrent dislocation.
- FIG. 5 is a graph demonstrating the temperature gradient through a portion of the skin as a function of both the wavelength of incident laser energy and die depth of laser radiation penetration. No external cooling is used.
- the graph demonstrates a change in temperature ( ⁇ T) of about 60 degrees Celsius and all curves are shown for die time point 1 millisecond following exposure to the laser energy.
- the graph shows three lines corresponding to laser wavelengths of 10.6 microns, 1.3- 1.4 microns and 1.06 microns.
- the present invention utilizes laser energy having a wavelength between about 1 and about
- This type of laser energy is most frequently produced by a Nd:YAG, Nd:YAP or Nd:YALO-type laser.
- a iaser operating at these wavelengths may either have a high repetition pulse rate or operate in a continuous wave mode.
- This laser has been investigated in die medical community as a general surgical and tissue welding device, but has not been used for collagen tissue shrinkage in the past. Indeed, die prior art teaches away from the use of laser energy at 1.3- 1.4 microns for shrinking human collagen.
- FIG 6 is a schematic view of a hand held temperature controlled collagen shnnkage device used in the method of die present mvention Modern instruments to provide dynamic cooling of the surface layers of tissue are well suited to these applications
- a typical handpiece 40 compnses the laser delivery device as well as vanous pcnpheral systems
- a fiber optic cable 42 guides the laser light mto the device
- a preferred embodiment of such a device contains a focusmg lens 44 and, optionally, other laser optics or mechamcal equipment including a beam splitter, focusmg knob and adjustable mounting means, thereby producing a laser focus spot 46 on the surface of the tissue above the collagen to be shrunk
- a separate electronic or other thermal detector 48 is useful Additionally a coolant spiay 50 can be provided through the handpiece or it could be provided witii another separate device
- a connection to a computer and the laser 52 will allow the device to utilize the electromc or other thermal
- cryogen spray would be tetrafluoroediane, C 2 H 2 F 4 , an environmentally compatible, non-toxic, non-flammable freon substitute.
- distance between die aperture of the spray valve and the skin surface should be maintained at about 20 millimeters.
- die surface of die skin is pre-cooled to as low as 0 degrees Celsius or lower, at a rate fast enough to cool the surface only but not dissipate heat from below about 400-500 microns below the surface.
- dunng the cooling step the target tissue remains at body temperature and is not cooled at all.
- a passive heat sink includes glass or sapphire tip probes, and otiier types of devices to lay on the surface of the skin.
- a dynamic type of heat sink will refer to those actively cooled by flowing gas or liquid, jets or spurts of coolant such as freon, and otiier active types of heat exchangers suitable for surface cooling while irradiating sub-surface portions of collagen tissue.
- FIG. 7 is a graph demonstrating the temperature gradient through a portion of the skin with precooling as a function of both the wavelength of incident laser energy and the deptii of laser radiation penetration.
- the graph demonstrates a change in temperature ( ⁇ T) of about 60 degrees Celsius.
- ⁇ T change in temperature
- precooling of the skin surface tissue for a period of 20 milliseconds was conducted immediately prior to exposure to laser energy. All curves arc shown for a time point 1 millisecond following exposure to the laser energy.
- the graph shows three lines corresponding to laser wavelengths of 10.6 microns, 1.3-1.4 microns and 1.06 microns.
- Scanners such as those manufactured by Sha ⁇ lan and Reliant Technologies are presently available. These devices utilize one or more rotating mirrors to scan the beam over a circular or other shaped area. Power density of the beam incident on die tissue can be adjusted manually or by computer control. Automatically scanned systems previously used to vaporize holes into tissue with complex shapes and precisely defined dimensions, can be used in collagen shrinking applications as well. Applications where large areas of tissue are to be irradiated with a certain predetermined spectrum or gradient of power density over those areas are particularly well suited for computer- controlled laser scanner systems.
- the electronic diermal sensor can be a fast response thermocouple like the OS40 series devices from Omega. This detector will analyze a 0.125 inch spot from 1 " away and accurately indicate temperature within 0.1 seconds, fast enough to servo the applied laser energy or to simply turn it off when the desired temperature has been reached.
- the safe and appropriate application of the laser energy requires accurate delivery of the laser energy to the target tissue.
- the laser energy can be delivered in a continuous or pulsed wave by means of a highly accurate fiber optic microprocessor controlled delivery system known.
- FIG. 8 is a schematic view of a microscope mounted scanner for a temperature controlled collagen shrinkage device used in the present invention.
- a laser console 60 is installed adjacent a floor-mounted microscope 62.
- a fiber optic cable 64 conducts laser energy from the laser source to the scanner 66.
- a laser delivery attachment 68 may be necessary to conduct die laser energy in an appropriate beam pattern and focus.
- servo feedback 70 signals are also conducted along die fiber optic back to the laser console. The servo feedback signals could also be directed back to the laser console via an additional fiber optic or other wiring or cabling.
- This servo feedback may comprise thermal or optical data obtained via exter.—i sensors or via internal systems, such as a fiber-tip protection system which attenuates die laser energy transmitted, to provide control in operation and to prevent thermal runaway in the laser delivery device.
- a thermal feedback controller 72 will regulate die laser energy being transmitted.
- This controller can comprise an analog or digital PI, PD or PID-type controller, a microprocessor and set of operating instructions, or any other controller known to those skilled in the art
- Other preferred embodiments can also be provided with additional features
- die surgeon or technician operating the laser could also manipulate an energy adjust knob 74, a calibration knob 76 and a footpedal 78
- a very accurately adjustable system is provided which allows a surgeon to deliver laser energy via a computer controlled scanning device, accordmg to mstructions given by the surgeon or an observer mspectmg the region of the skin where collagen is to be shrunk through a very accurate microscope
- die scanner can deliver a very precise, predetermined amount of laser energy, m precisely chosen, predetermined regions of the skin over specific, predetermined penods of time
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Electromagnetism (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Laser Surgery Devices (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU23181/97A AU2318197A (en) | 1996-04-10 | 1997-03-07 | Improved method and device for laser induced shrinking of collagen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63180096A | 1996-04-10 | 1996-04-10 | |
US08/631,800 | 1996-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997037723A1 true WO1997037723A1 (fr) | 1997-10-16 |
Family
ID=24532788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/003449 WO1997037723A1 (fr) | 1996-04-10 | 1997-03-07 | Procede et dispostif ameliores de retraction de collagene induite au laser |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2318197A (fr) |
WO (1) | WO1997037723A1 (fr) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998033558A1 (fr) * | 1997-02-05 | 1998-08-06 | Candela Corporation | Procede et appareil destines a traiter des rides de la peau au moyen d'un rayonnement |
WO1999061105A1 (fr) | 1998-05-28 | 1999-12-02 | Carl Baasel Lasertechnik Gmbh | Procede et dispositif pour chauffer superficiellement un tissu |
US6026816A (en) * | 1998-01-22 | 2000-02-22 | Candela Corporation | Method of treating sleep-disordered breathing syndromes |
WO2000044297A1 (fr) * | 1999-01-29 | 2000-08-03 | Candela Corporation | Refroidissement dynamique de tissus pour un traitement par rayonnement |
US6436094B1 (en) | 2000-03-16 | 2002-08-20 | Laserscope, Inc. | Electromagnetic and laser treatment and cooling device |
EP1139898A4 (fr) * | 1998-12-08 | 2003-09-10 | Joseph Neev | Application d'energie avec refroidissement |
US6743222B2 (en) | 1999-12-10 | 2004-06-01 | Candela Corporation | Method of treating disorders associated with sebaceous follicles |
US6869430B2 (en) | 2000-03-31 | 2005-03-22 | Rita Medical Systems, Inc. | Tissue biopsy and treatment apparatus and method |
EP1294444A4 (fr) * | 2000-04-03 | 2005-08-10 | Ceramoptec Gmbh | Systeme laser therapeutique fonctionnant entre 1000 et 1300 nm et son application |
US7041094B2 (en) | 1999-03-15 | 2006-05-09 | Cutera, Inc. | Tissue treatment device and method |
WO2006116141A1 (fr) * | 2005-04-22 | 2006-11-02 | Cynosure, Inc. | Procedes et systemes de traitement au laser mettant en application un faisceau de sortie non uniforme |
US7291140B2 (en) | 2003-07-18 | 2007-11-06 | Cutera, Inc. | System and method for low average power dermatologic light treatment device |
US7326199B2 (en) | 2003-12-22 | 2008-02-05 | Cutera, Inc. | System and method for flexible architecture for dermatologic treatments utilizing multiple light sources |
EP2056934A4 (fr) * | 2006-08-28 | 2010-04-28 | Univ California | Refroidissement dynamique de la peau humaine au moyen d'un cryogène non toxique sans appauvrissement en ozone et avec un potentiel de réchauffement planétaire minimal |
US7975702B2 (en) | 2005-04-05 | 2011-07-12 | El.En. S.P.A. | System and method for laser lipolysis |
US8814922B2 (en) | 2009-07-22 | 2014-08-26 | New Star Lasers, Inc. | Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure |
US8870856B2 (en) | 2003-08-25 | 2014-10-28 | Cutera, Inc. | Method for heating skin using light to provide tissue treatment |
US8915948B2 (en) | 2002-06-19 | 2014-12-23 | Palomar Medical Technologies, Llc | Method and apparatus for photothermal treatment of tissue at depth |
US8915906B2 (en) | 2003-08-25 | 2014-12-23 | Cutera, Inc. | Method for treatment of post-partum abdominal skin redundancy or laxity |
US9028469B2 (en) | 2005-09-28 | 2015-05-12 | Candela Corporation | Method of treating cellulite |
US9028536B2 (en) | 2006-08-02 | 2015-05-12 | Cynosure, Inc. | Picosecond laser apparatus and methods for its operation and use |
US9486285B2 (en) | 2006-06-14 | 2016-11-08 | Candela Corporation | Treatment of skin by spatial modulation of thermal heating |
US9730780B2 (en) | 2013-10-22 | 2017-08-15 | Biolux Research Ltd. | Intra-oral light-therapy apparatuses and methods for their use |
US9780518B2 (en) | 2012-04-18 | 2017-10-03 | Cynosure, Inc. | Picosecond laser apparatus and methods for treating target tissues with same |
US10245107B2 (en) | 2013-03-15 | 2019-04-02 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
US11418000B2 (en) | 2018-02-26 | 2022-08-16 | Cynosure, Llc | Q-switched cavity dumped sub-nanosecond laser |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4854320A (en) * | 1983-10-06 | 1989-08-08 | Laser Surgery Software, Inc. | Laser healing method and apparatus |
US4976709A (en) * | 1988-12-15 | 1990-12-11 | Sand Bruce J | Method for collagen treatment |
US5071417A (en) * | 1990-06-15 | 1991-12-10 | Rare Earth Medical Lasers, Inc. | Laser fusion of biological materials |
US5334191A (en) * | 1992-05-21 | 1994-08-02 | Dix Phillip Poppas | Laser tissue welding control system |
-
1997
- 1997-03-07 WO PCT/US1997/003449 patent/WO1997037723A1/fr active Application Filing
- 1997-03-07 AU AU23181/97A patent/AU2318197A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4854320A (en) * | 1983-10-06 | 1989-08-08 | Laser Surgery Software, Inc. | Laser healing method and apparatus |
US4976709A (en) * | 1988-12-15 | 1990-12-11 | Sand Bruce J | Method for collagen treatment |
US5071417A (en) * | 1990-06-15 | 1991-12-10 | Rare Earth Medical Lasers, Inc. | Laser fusion of biological materials |
US5334191A (en) * | 1992-05-21 | 1994-08-02 | Dix Phillip Poppas | Laser tissue welding control system |
Cited By (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998033558A1 (fr) * | 1997-02-05 | 1998-08-06 | Candela Corporation | Procede et appareil destines a traiter des rides de la peau au moyen d'un rayonnement |
US6120497A (en) * | 1997-02-05 | 2000-09-19 | Massachusetts General Hospital | Method and apparatus for treating wrinkles in skin using radiation |
US6659999B1 (en) | 1997-02-05 | 2003-12-09 | Candela Corporation | Method and apparatus for treating wrinkles in skin using radiation |
US6026816A (en) * | 1998-01-22 | 2000-02-22 | Candela Corporation | Method of treating sleep-disordered breathing syndromes |
US6514278B1 (en) | 1998-05-28 | 2003-02-04 | Carl Baasel Lasertechnik Gmbh | Method and device for the superficial heating of tissue |
WO1999061105A1 (fr) | 1998-05-28 | 1999-12-02 | Carl Baasel Lasertechnik Gmbh | Procede et dispositif pour chauffer superficiellement un tissu |
DE19823947A1 (de) * | 1998-05-28 | 1999-12-02 | Baasel Carl Lasertech | Verfahren und Vorrichtung zum oberflächlichen Erwärmen von Gewebe |
AU743377B2 (en) * | 1998-05-28 | 2002-01-24 | Carl Baasel Lasertechnik Gmbh | Method and device for the superficial heating of tissue |
EP1139898A4 (fr) * | 1998-12-08 | 2003-09-10 | Joseph Neev | Application d'energie avec refroidissement |
US6514244B2 (en) | 1999-01-29 | 2003-02-04 | Candela Corporation | Dynamic cooling of tissue for radiation treatment |
US6200308B1 (en) | 1999-01-29 | 2001-03-13 | Candela Corporation | Dynamic cooling of tissue for radiation treatment |
WO2000044297A1 (fr) * | 1999-01-29 | 2000-08-03 | Candela Corporation | Refroidissement dynamique de tissus pour un traitement par rayonnement |
US7465307B2 (en) | 1999-03-15 | 2008-12-16 | Cutera, Inc. | Tissue treatment system |
US7041094B2 (en) | 1999-03-15 | 2006-05-09 | Cutera, Inc. | Tissue treatment device and method |
US7618414B2 (en) | 1999-03-15 | 2009-11-17 | Cutera, Inc. | Tissue treatment system |
US6743222B2 (en) | 1999-12-10 | 2004-06-01 | Candela Corporation | Method of treating disorders associated with sebaceous follicles |
US6436094B1 (en) | 2000-03-16 | 2002-08-20 | Laserscope, Inc. | Electromagnetic and laser treatment and cooling device |
US6869430B2 (en) | 2000-03-31 | 2005-03-22 | Rita Medical Systems, Inc. | Tissue biopsy and treatment apparatus and method |
US7025765B2 (en) | 2000-03-31 | 2006-04-11 | Rita Medical Systems, Inc. | Tissue biopsy and treatment apparatus and method |
EP1294444A4 (fr) * | 2000-04-03 | 2005-08-10 | Ceramoptec Gmbh | Systeme laser therapeutique fonctionnant entre 1000 et 1300 nm et son application |
US10556123B2 (en) | 2002-06-19 | 2020-02-11 | Palomar Medical Technologies, Llc | Method and apparatus for treatment of cutaneous and subcutaneous conditions |
US10500413B2 (en) | 2002-06-19 | 2019-12-10 | Palomar Medical Technologies, Llc | Method and apparatus for treatment of cutaneous and subcutaneous conditions |
US8915948B2 (en) | 2002-06-19 | 2014-12-23 | Palomar Medical Technologies, Llc | Method and apparatus for photothermal treatment of tissue at depth |
US7291140B2 (en) | 2003-07-18 | 2007-11-06 | Cutera, Inc. | System and method for low average power dermatologic light treatment device |
US8870856B2 (en) | 2003-08-25 | 2014-10-28 | Cutera, Inc. | Method for heating skin using light to provide tissue treatment |
US8915906B2 (en) | 2003-08-25 | 2014-12-23 | Cutera, Inc. | Method for treatment of post-partum abdominal skin redundancy or laxity |
US7326199B2 (en) | 2003-12-22 | 2008-02-05 | Cutera, Inc. | System and method for flexible architecture for dermatologic treatments utilizing multiple light sources |
US7975702B2 (en) | 2005-04-05 | 2011-07-12 | El.En. S.P.A. | System and method for laser lipolysis |
US8113209B2 (en) | 2005-04-05 | 2012-02-14 | Cynosure, Inc. | Sub-dermal laser skin treatment |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
WO2006116141A1 (fr) * | 2005-04-22 | 2006-11-02 | Cynosure, Inc. | Procedes et systemes de traitement au laser mettant en application un faisceau de sortie non uniforme |
US8322348B2 (en) | 2005-04-22 | 2012-12-04 | Cynosure, Inc. | Methods and systems for laser treatment using non-uniform output beam |
US8317779B2 (en) | 2005-04-22 | 2012-11-27 | Cynosure, Inc. | Methods and systems for laser treatment using non-uniform output beam |
US10434324B2 (en) | 2005-04-22 | 2019-10-08 | Cynosure, Llc | Methods and systems for laser treatment using non-uniform output beam |
US9028469B2 (en) | 2005-09-28 | 2015-05-12 | Candela Corporation | Method of treating cellulite |
US9486285B2 (en) | 2006-06-14 | 2016-11-08 | Candela Corporation | Treatment of skin by spatial modulation of thermal heating |
US10966785B2 (en) | 2006-08-02 | 2021-04-06 | Cynosure, Llc | Picosecond laser apparatus and methods for its operation and use |
US10849687B2 (en) | 2006-08-02 | 2020-12-01 | Cynosure, Llc | Picosecond laser apparatus and methods for its operation and use |
US11712299B2 (en) | 2006-08-02 | 2023-08-01 | Cynosure, LLC. | Picosecond laser apparatus and methods for its operation and use |
US9028536B2 (en) | 2006-08-02 | 2015-05-12 | Cynosure, Inc. | Picosecond laser apparatus and methods for its operation and use |
EP2056934A4 (fr) * | 2006-08-28 | 2010-04-28 | Univ California | Refroidissement dynamique de la peau humaine au moyen d'un cryogène non toxique sans appauvrissement en ozone et avec un potentiel de réchauffement planétaire minimal |
US8814922B2 (en) | 2009-07-22 | 2014-08-26 | New Star Lasers, Inc. | Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure |
US10581217B2 (en) | 2012-04-18 | 2020-03-03 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US12068571B2 (en) | 2012-04-18 | 2024-08-20 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US10305244B2 (en) | 2012-04-18 | 2019-05-28 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US12431683B2 (en) | 2012-04-18 | 2025-09-30 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US11664637B2 (en) | 2012-04-18 | 2023-05-30 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US9780518B2 (en) | 2012-04-18 | 2017-10-03 | Cynosure, Inc. | Picosecond laser apparatus and methods for treating target tissues with same |
US11095087B2 (en) | 2012-04-18 | 2021-08-17 | Cynosure, Llc | Picosecond laser apparatus and methods for treating target tissues with same |
US11446086B2 (en) | 2013-03-15 | 2022-09-20 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
US10765478B2 (en) | 2013-03-15 | 2020-09-08 | Cynosurce, Llc | Picosecond optical radiation systems and methods of use |
US10245107B2 (en) | 2013-03-15 | 2019-04-02 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
US10285757B2 (en) | 2013-03-15 | 2019-05-14 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
US12193734B2 (en) | 2013-03-15 | 2025-01-14 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
US9730780B2 (en) | 2013-10-22 | 2017-08-15 | Biolux Research Ltd. | Intra-oral light-therapy apparatuses and methods for their use |
US12251283B2 (en) | 2013-10-22 | 2025-03-18 | Biolux Group Sa | Intra-oral light-therapy apparatuses and methods for their use |
US10729524B2 (en) | 2013-10-22 | 2020-08-04 | Biolux Research Holdings, Inc. | Intra-oral light-therapy apparatuses and methods for their use |
US11418000B2 (en) | 2018-02-26 | 2022-08-16 | Cynosure, Llc | Q-switched cavity dumped sub-nanosecond laser |
US11791603B2 (en) | 2018-02-26 | 2023-10-17 | Cynosure, LLC. | Q-switched cavity dumped sub-nanosecond laser |
Also Published As
Publication number | Publication date |
---|---|
AU2318197A (en) | 1997-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997037723A1 (fr) | Procede et dispostif ameliores de retraction de collagene induite au laser | |
AU742982B2 (en) | Pulsed filament lamp for dermatological treatment | |
US7094252B2 (en) | Enhanced noninvasive collagen remodeling | |
Ross et al. | Why does carbon dioxide resurfacing work?: a review | |
US6106514A (en) | Laser method for subsurface cutaneous treatment | |
US5968034A (en) | Pulsed filament lamp for dermatological treatment | |
Thomsen | Pathologic analysis of photothermal and photomechanical effects of laser–tissue interactions | |
Reid et al. | Q-switched ruby laser treatment of black tattoos | |
US7217265B2 (en) | Treatment of cellulite with mid-infrared radiation | |
US8323253B2 (en) | Method and device for tightening tissue using electromagnetic radiation | |
US6176854B1 (en) | Percutaneous laser treatment | |
US20050055073A1 (en) | Facial tissue strengthening and tightening device and methods | |
US20070173799A1 (en) | Treatment of fatty tissue adjacent an eye | |
JP6185580B2 (ja) | 皮膚処置のための方法および装置 | |
Gardner et al. | In vitro changes in non‐facial human skin following CO2 laser resurfacing: a comparison study | |
Sanniec et al. | Long-term assessment of perioral rhytide correction with erbium: YAG laser resurfacing | |
Wang et al. | Efficacy and safety of high-intensity, high-frequency, parallel ultrasound beams for fine lines and wrinkles | |
Wong et al. | Ultrasound therapy for the skin | |
Bonan et al. | Laser‐assisted blepharoplasty: an innovative safe and effective technique | |
Rejuvenation | Energy-based devices in male skin rejuvenation | |
Warner et al. | Laser hair removal | |
Feng et al. | Treatment of trapdoor deformity using erbium-doped Yttrium Aluminum Garnet laser | |
Minaev | Laser apparatus for surgery and force therapy based on high-power semiconductor and fibre lasers | |
Choi et al. | Infrared imaging of CO2 laser ablation: implications for laser skin resurfacing | |
Welch et al. | Lasers in medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97536188 Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |